Krystal Biotech Q3 Earnings Preview

Krystal Biotech (KRYS) is scheduled to announce Q3 earnings results on Monday, November 2nd, before market open. - The consensus EPS Estimate is $1.92 (-27.8% Y/Y) and the consensus Revenue Estimate is $126.54M (+29.4% Y/Y). - Over the last 2 years, KRYS